☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Sobi and ADC Therapeutics Zynlonta (loncastuximab tesirine) Receives EC’s Conditional Marketing Authorisation for Diffuse Large B-...
December 21, 2022
Anzac Animal Health’s Zycosan Receives the US FDA’s Approval as First Injectable
December 21, 2022
Altimmune Reports 24-Week (12-Week Extension) Trial Results of Pemvidutide for the Treatment of Non-Alcoholic Fatty Liver Disease
December 21, 2022
Sosei Heptares Partner Pfizer Report the First Patient Dosing of PF-07081532 in the P-II Clinical Trial for the Treatment of Type...
December 21, 2022
Radius Health's Tymlos (abaloparatide) Receives the US FDA’s Approval for the Treatment of Osteoporosis
December 21, 2022
Verona Pharma Reports P-III Trial (ENHANCE-1) Results of Ensifentrine for the Treatment of Chronic Obstructive Pulmonary Disease
December 21, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions